SERYNTH FAST RELIEF NASAL

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
SERYNTH FAST RELIEF NASAL
Generic name
NAPHAZOLINE HCL 0.05% FAST RELIEF NASAL
Manufacturer
Jiangxi Yudexi Pharmaceutical Co., LTD
Product type
HUMAN OTC DRUG
SPL set ID
4a4abdc0-aded-1b8a-e063-6394a90a9b56
SPL ID
572991c4-c664-d0b7-e063-6394a90ae600
Version
2
Effective date
2026-07-21
Source export date
2026-11-13
Source partition
7
Source file
https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/875ce92e4370b2000cf566c8a9c0e4d02cceccd3a3b18a8b0b87928b28506f0b/drug-label-0007-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 16:34:27
Harmonized routes table
Harmonized routes
NASAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Ask a doctor before use if you have ·heart disease ·high blood pressure .thyroid disease ·diabetes ·trouble urinating due to enlarged prostate gland

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.